Figure 1From: Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular diseaseCirculating levels of glucagon-like peptide-1 (GLP-1) in patients with metabolic syndrome (MetS) and pre-MetS conditions. Scatter plot showing the GLP-1 (ng/mL) in patients with pre-MetS conditions (n = 37) and MetS (n = 60). The bars indicate the mean values.Back to article page